The Immediate Preoperative Anastrozole, Tamoxifen, or Combined With Tamoxifen (IMPACT) trial was designed to test the hypothesis that the clinical and/or biologic effects of neoadjuvant tamoxifen ...
Anastrozole, a daily pill to prevent breast cancer, will now be available to thousands of more women in the UK after being cleared for wider use. The drug has been used to treat hormone-driven breast ...
Objective: To determine the recommended clinical dosage in Japan of a new aromatase inhibitor, anastrozole. Design and Setting: A randomised, nonblinded, dose-comparative clinical pharmacology study ...
Autoimmune hepatitis is a rare but serious complication of anastrozole therapy that may present with strikingly abnormal liver function values.
A drug previously used to treat breast cancer is now being offered to high risk women as a preventative measure. It has previously been used to treat breast cancer but has been “repurposed” to prevent ...
Double-Blind, Randomized Trial Comparing the Efficacy and Tolerability of Fulvestrant Versus Anastrozole in Postmenopausal Women With Advanced Breast Cancer Progressing on Prior Endocrine Therapy: ...
The news that the U.K. has approved a preventive drug for post-menopausal women at risk of developing breast cancer wasn’t a shock to breast medical oncologist Abenaa Brewster. But the fact that a ...
Post-menopausal women in the UK who are at a higher risk of breast cancer may soon have wider access to a medicine called anastrozole to reduce their chance of developing it. The drug, which is taken ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results